felin
infecti
periton
fip
lethal
infecti
diseas
affect
domest
wild
cat
sever
report
suggest
tnfalpha
relat
progress
fip
thu
administr
felin
tnfalphaneutr
antibodi
cat
fip
may
reduc
diseas
progress
studi
prepar
nine
monoclon
antibodi
mab
recogn
felin
tnfalpha
mab
neutral
recombin
tnfalpha
inhibitori
concentr
mab
cytotox
recombin
tnfalpha
ngml
mab
exhibit
high
neutral
activ
natur
tnfalpha
deriv
fipvinfect
macrophag
confirm
inhibit
follow
felin
tnfalphainduc
condit
vitro
increas
surviv
rate
neutrophil
cat
fip
ii
aminopeptidas
n
apn
mrna
express
macrophag
iii
apoptosi
felin
tlymphocyt
cell
line
tumor
necrosi
factor
tnf
alpha
mainli
produc
transmembran
protein
membraneform
tnfalpha
activ
macrophag
membraneform
tnfalpha
releas
cell
surfac
nonglycosyl
protein
solubleform
tnfalpha
action
metalloproteinas
tnfalphaconvert
enzym
tace
enter
circul
homotrim
moss
et
al
smith
baglioni
homotrim
tnfalpha
bind
cell
surfac
tnf
receptor
tnfr
induc
variou
physiolog
activ
vandenabeel
et
al
reinhard
et
al
exampl
bind
cell
surfac
caspas
activ
induc
apoptosi
bind
cell
surfac
transcript
factor
nfkb
cjun
activ
promot
cell
prolifer
induc
express
cytokin
involv
immun
inflamm
tnfalpha
induc
necrosi
apoptosi
tumor
cell
activ
lymphocyt
macrophag
howev
overproduct
tnfalpha
lead
acut
inflamm
immun
system
abnorm
human
anim
report
tnfalpha
close
relat
progress
inflammatori
diseas
rheumatoid
arthriti
psoriasi
inflammatori
bowel
diseas
kollia
et
al
brota
et
al
wang
fu
moreov
previou
studi
describ
aggrav
patholog
viral
infect
human
immunodefici
viru
influenza
viru
dengu
viru
infect
due
increas
tnfalpha
product
fauci
mauri
poli
et
al
uchid
et
al
yen
et
al
felin
infecti
periton
viru
fip
viru
fipv
felin
coronaviru
fcov
famili
coronavirida
caus
fatal
diseas
call
fip
wild
domest
cat
sever
organ
includ
liver
lung
spleen
central
nervou
system
affect
cat
develop
fip
format
lesion
organ
accompani
necrosi
pyogen
granulomat
inflamm
pedersen
pleural
effus
ascit
fluid
shown
accumul
fip
cat
macrophagesmonocyt
play
import
role
pathogenesi
fip
exampl
differ
prolifer
macrophagesmonocyt
shown
relat
differ
pathogen
felin
enter
coronaviru
fecv
fipv
dewerchin
et
al
stoddart
scott
previous
show
viru
replic
macrophag
induc
tnfalpha
product
tnfalpha
produc
fipvinfect
macrophag
involv
lymphopenia
increas
level
cellular
receptor
type
ii
fipv
aminopeptidas
n
apn
takano
et
al
b
moreov
report
neutrophil
apoptosi
cat
fip
inhibit
tnfalpha
find
suggest
neutrophilia
cat
fip
due
tnfalphainduc
neutrophil
surviv
takano
et
al
past
forti
year
sever
studi
investig
potenti
treatment
fip
hartmann
ritz
antivir
immunostimul
immunosuppress
drug
experiment
use
treatment
fip
none
exhibit
suffici
therapeut
effect
sever
agent
significantli
inhibit
fcov
replic
vitro
identifi
balzarini
et
al
barlough
shacklett
hsieh
et
al
kim
et
al
howev
whether
agent
exhibit
therapeut
effect
cat
fip
investig
human
human
tnfalpha
activityneutr
antibodi
use
therapeut
drug
rheumatoid
arthriti
inflammatori
bowel
diseas
suffici
therapeut
effect
achiev
tracey
et
al
find
suggest
fip
symptom
may
also
reduc
felin
tnfalphaneutr
antibodi
cat
fip
howev
felin
tnfalphaneutr
antibodi
develop
attempt
prepar
monoclon
antibodi
mab
recogn
felin
tnfalpha
antifelin
tnfalpha
mab
investig
whether
mab
inhibit
felin
tnfalpha
activ
furthermor
investig
applic
antifelin
tnfalpha
mab
therapeut
drug
fip
vitro
fo
mous
myeloma
cell
atcc
hybridoma
cell
produc
antibodi
felin
tnfalpha
maintain
dulbecco
modifi
eagl
minimum
essenti
medium
supplement
fc
antibiot
alveolar
macrophag
neutrophil
murin
sarcoma
cell
atcc
fetj
felin
tlymphocyt
cell
maintain
rpmi
growth
medium
supplement
fc
antibiot
lm
lgml
polybren
fo
mous
myeloma
cell
murin
sarcoma
cell
obtain
american
type
cultur
collect
fetj
cell
kindli
provid
dr
yamamoto
univers
florida
usa
type
ii
fipv
strain
grown
feli
catu
whole
cell
fipv
strain
suppli
dr
horzinek
state
univers
utrecht
netherland
balbc
mice
approxim
week
age
inocul
intraperiton
mixtur
lg
commerci
recombin
felin
tnfalpha
r
b
system
usa
complet
freund
adjuv
mice
receiv
intraperiton
booster
dose
lg
recombin
tnfalpha
everi
three
four
week
boost
repeat
four
five
time
spleen
cell
obtain
three
day
final
immun
fusion
carri
essenti
method
describ
milstein
milstein
merck
germani
use
fuse
agent
ratio
mous
spleen
sell
mous
myeloma
cell
fo
select
medium
contain
hypoxanthin
aminopterin
thymidin
fuse
cell
concentr
cellsml
dispens
volum
well
flatbottom
micropl
incub
humid
atmospher
contain
co
incub
week
well
examin
contain
hybridoma
cultur
screen
product
recombin
tnfalpha
specif
antibodi
enzymelink
immunosorb
assay
see
coloni
antibodyposit
well
passag
multipl
incub
medium
contain
hypoxanthin
thymidin
cell
clone
limit
dilut
method
elisa
plate
sumitomo
bakelit
co
ltd
japan
coat
overnight
recombin
tnfalpha
llwell
dilut
carbon
buffer
ph
wash
phosphat
buffer
salin
pb
contain
plate
block
block
buffer
contain
skim
milk
pb
min
well
plate
receiv
hybridoma
cultur
supernat
min
incub
plate
wash
mixtur
peroxidas
pod
conjug
goat
antimous
southern
biotechnolog
associ
inc
usa
pod
conjug
goat
antimous
southern
biotechnolog
associ
inc
usa
ad
well
plate
incub
min
plate
wash
well
receiv
substrat
solut
follow
incub
min
dark
substrat
solut
prepar
dissolv
ophenylenediamin
dihydrochlorid
concentr
mgml
citric
acid
na
hpo
buffer
ph
ad
llml
h
reaction
stop
n
h
solut
optic
densiti
od
nm
determin
hybridoma
cultur
supernat
use
determin
antibodi
class
subclass
mous
mab
isotyp
test
kit
serotec
ltd
uk
accord
product
manual
mab
purifi
hybridoma
cultur
supernat
protein
g
sepharos
ge
healthcar
usa
accord
product
manual
purif
buffer
mab
exchang
pb
ph
amicon
centrifug
filter
devic
nmwl
millipor
usa
concentr
purifi
mab
assay
bradford
method
recombin
tnfalpha
fipvinfect
macrophag
cultur
supernat
contain
natur
tnfalpha
run
use
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
transfer
nitrocellulos
membran
protein
marker
precis
plu
protein
blue
standard
purchas
biorad
blot
block
nonfat
dri
milk
powder
tbst
mm
trishcl
ph
nacl
h
follow
h
incub
antifelin
tnfalpha
mab
follow
wash
membran
incub
horseradish
peroxidas
conjug
goat
antimous
h
visual
substrat
min
cell
suspend
densiti
cellsml
dilut
medium
contain
lgml
actinomycin
sigma
lab
usa
preincub
h
serial
dilut
mab
mix
ngml
recombin
tnfalpha
fipvinfect
macrophag
cultur
supernat
use
natur
felin
tnfalpha
sampl
final
concentr
mixtur
incub
h
preincub
cell
seed
volum
well
plate
fifti
microlit
mixtur
ad
well
incub
h
solut
cell
prolifer
assay
kit
kishida
chemic
co
ltd
japan
ad
cell
return
incub
h
absorb
formazan
produc
measur
nm
spectrophotometr
plate
reader
describ
manufactur
percent
neutral
calcul
follow
formula
neutral
od
well
contain
mab
sampl
od
well
contain
sampl
alon
od
well
without
mab
sampl
type
ii
fipv
strain
tcid
ml
administ
oral
spf
cat
nine
cat
develop
fip
symptom
fip
cat
fever
weight
loss
periton
pleural
effus
dyspnea
ocular
lesion
neural
symptom
nine
spf
cat
control
use
studi
fip
diagnosi
confirm
upon
postmortem
examin
reveal
periton
pleural
effus
pyogranuloma
major
organ
experi
perform
accord
guidelin
anim
experi
kitasato
univers
separ
felin
neutrophil
perform
describ
takano
et
al
briefli
heparin
blood
ml
cat
dilut
pb
subject
ficollhypaqu
densiti
gradient
centrifug
min
remov
peripher
blood
mononuclear
cell
supernat
aspir
top
layer
pellet
mix
equal
volum
salin
contain
dextran
separ
granulocyt
allow
stand
min
c
top
clear
layer
centrifug
min
pellet
mix
ml
nacl
min
elimin
contamin
erythrocyt
mix
ml
nacl
cell
wash
three
time
pb
resuspend
growth
medium
cell
puriti
assess
neutrophil
examin
smear
stain
wrightgiemsa
solut
felin
neutrophil
seed
plate
cultur
presenc
recombin
tnfalpha
final
concentr
ngml
ngml
andor
antifelin
tnfalpha
mab
final
concentr
lgml
h
incub
solut
ad
cell
return
incub
h
absorb
measur
describ
percent
viabil
calcul
follow
formula
cell
viabil
incub
odprior
incub
od
total
cellular
rna
extract
macrophag
use
high
pure
rna
isol
kit
roch
diagnost
switzerland
accord
instruct
manufactur
rna
dissolv
elut
buffer
use
total
cellular
rna
templat
cdna
synthes
use
readytogo
rtpcr
bead
ge
healthcar
life
scienc
usa
revers
transcript
perform
final
volum
contain
lg
oligo
dt
primer
result
solut
incub
h
synthes
cdna
cdna
amplifi
pcr
use
specif
primer
felin
gapdh
fapn
primer
sequenc
shown
tabl
pcr
perform
total
volum
one
microlit
sampl
cdna
mix
concentr
reaction
buffer
takara
japan
deoxynucleotid
mix
takara
japan
contain
mm
lm
primer
mix
ex
taq
polymeras
u
takara
japan
distil
water
use
pcr
thermal
cycler
dice
takara
japan
dna
amplifi
min
follow
cycl
denatur
primer
anneal
synthesi
final
extens
min
pcr
product
resolv
electrophoresi
agaros
gel
gel
incub
sybr
green
nucleic
acid
gel
stain
roch
diagnost
switzerland
band
visual
use
uv
transillumin
nm
photograph
band
densiti
quantifi
appropri
uv
exposur
video
densitometri
use
imag
j
nih
usa
fapn
mrna
quantit
analyz
term
rel
densiti
valu
mrna
housekeep
gene
gapdh
felin
alveolar
macrophag
obtain
bronchoalveolar
lavag
hank
balanc
salt
solut
hbss
spf
cat
previous
describ
hohdatsu
et
al
felin
alveolar
macrophag
cell
cultur
medium
contain
recombin
tnfalpha
ngml
andor
antifelin
tnfalpha
mab
lgml
cell
collect
cultur
day
fapn
mrna
express
level
measur
recombin
tnfalpha
ngml
hybridoma
cultur
supernat
final
concentr
mix
incub
fetj
cell
cell
cultur
h
mixtur
examin
apoptosisinduc
activ
apoptot
cell
detect
tunel
accord
method
takano
et
al
data
two
group
analyz
student
test
multipl
group
analyz
oneway
anova
cell
fusion
conduct
time
use
spleen
cell
mice
immun
recombin
tnfalpha
screen
elisa
reveal
hybridoma
form
immunoglobulin
isotyp
polypeptid
specif
mab
secret
hybridoma
shown
tabl
fig
mab
test
reactiv
recombin
tnfalpha
use
western
blot
five
mab
abl
detect
band
fig
reactiv
natur
tnfalpha
contain
fipvinfect
macrophag
cultur
supernat
similarli
confirm
seven
mab
abl
detect
band
fig
mab
test
neutral
activ
recombin
tnfalpha
cytotox
assay
system
dose
requir
inhibit
cell
death
valu
use
paramet
evalu
neutral
activ
mab
reactiv
mab
felin
tnfalpha
western
blot
analysi
recombin
tnfalpha
fipvinfect
macrophag
cultur
supernat
contain
natur
tnfalpha
run
use
sdspage
transfer
nitrocellulos
membran
blot
block
nonfat
dri
milk
powder
h
follow
h
incub
antifelin
tnfalpha
mab
follow
wash
membran
incub
horseradish
peroxidas
conjug
goat
antimous
h
visual
substrat
min
control
igg
antiglutathion
stransferas
mous
mab
mab
neutral
recombin
tnfalpha
activ
concentrationdepend
manner
mab
mab
show
markedli
higher
neutral
activ
tabl
fig
natur
tnfalphaneutr
activ
mab
evalu
fipvinfect
macrophag
cultur
supernat
use
natur
tnfalpha
three
mab
select
base
recombin
tnfalphaneutr
activ
analyz
determin
whether
inhibit
natur
tnfalpha
cytotox
cell
mab
exhibit
strong
neutral
activ
indic
exhibit
strong
neutral
activ
recombin
natur
tnfalpha
tabl
fig
tnfalphainduc
increas
surviv
rate
neutrophil
cat
fip
previous
report
takano
et
al
increas
neutrophil
also
suggest
aggrav
patholog
fip
base
report
investig
whether
mab
inhibit
recombin
tnfalphainduc
elev
surviv
rate
neutrophil
surviv
rate
cell
significantli
higher
presenc
ngml
recombin
tnfalpha
medium
alon
fig
hand
surviv
rate
cell
significantli
lower
presenc
ngml
recombin
tnfalpha
mab
recombin
tnfalpha
alon
tnfalpha
elev
fapn
express
level
macrophag
fipv
infect
viral
product
shown
increas
macrophag
takano
et
al
investig
whether
mab
inhibit
recombin
tnfalphainduc
increas
fapn
mrna
express
level
fapn
mrna
express
level
felin
alveolar
macrophag
significantli
higher
presenc
recombin
tnfalpha
medium
alon
fig
hand
fapn
mrna
express
level
significantli
lower
presenc
recombin
tnfalpha
mab
recombin
tnfalpha
alon
tnfalpha
induc
apoptosi
lymphocyt
especi
lymphocyt
result
decreas
cellmedi
immun
takano
et
al
investig
whether
mab
inhibit
recombin
tnfalphainduc
apoptosi
lymphocyt
use
felin
tlymphocyt
cell
line
fetj
cell
histogram
fluoresc
intens
fetj
cell
measur
use
flow
cytometri
shown
fig
bimod
peak
note
histogram
fetj
cell
react
recombin
tnfalpha
indic
apoptosi
induc
posit
rate
apoptot
cell
significantli
higher
presenc
recombin
tnfalpha
medium
alon
hand
posit
rate
apoptot
cell
significantli
lower
presenc
recombin
tnfalpha
mab
recombin
tnfalpha
alon
fig
felin
tnfalphaneutr
mab
previous
prepar
prepar
nine
monoclon
antibodi
mab
recogn
felin
tnfalpha
immun
mice
recombin
felin
tnfalpha
mab
produc
exhibit
differ
reactiv
recombin
natur
felin
tnfalpha
contain
fipvinfect
macrophag
cultur
supernat
use
western
blot
western
blot
tnfalpha
degener
treatment
mab
react
either
recombin
natur
tnfalpha
result
suggest
mab
recogn
conform
epitop
tnfalpha
contrast
mab
react
natur
tnfalpha
howev
detail
antigenrecogn
properti
could
clarifi
recombin
tnfalpha
form
monom
wherea
natur
tnfalpha
form
homotrim
suggest
recombin
tnfalpha
monomer
form
natur
tnfalpha
trimetr
form
r
b
system
product
data
sheet
therefor
mab
may
recogn
trimetr
tnfalpha
saijo
et
al
describ
prepar
trimer
human
tnfalpharecogn
mab
saijo
et
al
show
weak
reactiv
mab
observ
monomer
tnfalpha
dissoci
trimer
tnfalpha
deterg
mab
react
immobil
monomer
tnfalpha
elisa
smith
baglioni
show
monomer
tnfalpha
bound
one
anoth
form
trimer
tnfalpha
solut
contain
degener
agent
indic
recombin
tnfalpha
also
form
trimer
solut
contain
deterg
react
elisa
smith
baglioni
therefor
find
suggest
mab
possess
similar
properti
mab
although
prepar
mab
possess
recombin
tnfalphaneutr
activ
strength
activ
vari
among
mab
mab
possess
strongest
recombin
tnfalphaneutr
activ
level
time
higher
mab
valu
mab
recombin
tnfalpha
ngml
respect
valu
antihuman
tnfalpha
antibodi
use
therapeut
drug
adalimumab
report
ng
ml
suggest
mab
possess
neutral
activ
equival
stronger
adalimumab
song
et
al
measur
natur
tnfalphaneutr
activ
mab
three
mab
select
base
recombin
tnfalphaneutr
activ
mab
high
medium
recombin
tnfalphaneutr
activ
mab
intermedi
activ
mab
compar
recombin
natur
tnfalphaneutr
activ
mab
natur
tnfalpha
use
concentr
exhibit
specif
activ
level
similar
cytotox
recombin
tnfalpha
ngml
cell
natur
tnfalphaneutr
activ
level
mab
decreas
approxim
recombin
tnfalphaneutr
activ
level
wherea
activ
mab
decreas
approxim
show
decreas
neutral
activ
among
mab
smallest
mab
therefor
result
demonstr
mab
effici
neutral
felin
tnfalpha
lower
dose
mab
cat
fip
neutrophilia
increas
apn
macrophag
lymphopenia
induc
cat
fip
tnfalpha
produc
fipvinfect
macrophag
takano
et
al
takano
et
al
b
investig
effect
mab
patholog
fip
vitro
confirm
neutral
felin
tnfalpha
activ
mab
inhibit
increas
surviv
rate
neutrophil
cat
fip
ii
apn
mrna
express
macrophag
iii
apoptosi
felin
tlymphocyt
cell
line
sever
drug
treat
fip
report
mostli
aim
antivir
action
hartmann
ritz
balzarini
et
al
barlough
shacklett
hsieh
et
al
kim
et
al
howev
fip
viral
infect
caus
immunemedi
inflammatori
diseas
combin
mab
prepar
use
alreadi
report
antifipv
agent
may
elimin
viru
inhibit
inflammatori
reaction
current
steroid
mainli
use
inhibit
inflammatori
reaction
fip
howev
steroid
also
inhibit
immun
system
use
elimin
fipv
sinc
mab
specif
inhibit
tnfalpha
factor
aggrav
patholog
fip
may
appropri
steroid
mab
mousederiv
protein
administr
larg
dose
mous
antibodi
xenogen
cat
may
induc
anaphylact
reaction
umehashi
et
al
report
administr
mab
constant
region
convert
felin
form
mousefelin
chimer
antibodi
induc
anaphylact
reaction
umehashi
et
al
reduc
side
effect
modif
mab
mousefelin
chimer
antibodi
employ
recombin
dna
techniqu
need
conclus
antifelin
tnfalpha
mab
prepar
us
appear
use
treatment
fip
vitro
modif
mab
mousefelin
chimer
antibodi
investig
vivo
effect
mab
may
lead
applic
new
therapeut
drug
fip
